POC tests for UTIs and other bacterial infections
This article was originally published in Start Up
Spectromics Ltd. was formed to license and commercialize technology that can detect bacterial susceptibility to drugs in only 10 minutes by detecting the underlying metabolism of pathogens. The start-up aims to incorporate it into a POC test that doctors can use to expose a patient's urine sample to eight different antibiotics, to see which can kill the bugs and which meet resistance.
You may also be interested in...
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
La Jolla’s formulation appears blocked by Amivas’ seven-year orphan exclusivity, and the company also will miss out on chance for a tropical disease priority review voucher; Amivas worked with the US Army to bring the severe malaria treatment through final stages of development and regulatory review.